Point-spectroscopy Trial

NCT05183698 | Terminated

• 1 other identifier: 20-002
• Study Type: observational
• Target: 11
• Locations: 1 country
• Sites: 1

Brief Summary

Evaluation and characterization of autofluorescence signals of tissue in and around wounds as identified by MolecuLight fluorescence image.

Conditions

Wound; Wound of Skin

Outcome Measures

Primary Outcomes (1)

• Spectra of autofluorescent signatures of tissue in and around the wounds

  Spectral characterization (i.e. emission curve including intensity) of the autofluorescence signal from wound tissue and surrounding tissue will be catalogued from all 50 study participants.

  2 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with chronic and/or acute wound

You may qualify if:

• Patients presenting with acute or chronic wounds
• years or older
• Willing to consent

You may not qualify if:

• Treatment with an investigational drug within 1 month of enrolment
• Any contra-indication to regular wound care
• Inability or unwillingness to consent

Sponsors & Collaborators

• MolecuLight Inc.: lead

Study Sites (1)

Judy Dan Centre for Hyperbaric Medicine & Advance Wound Care

North York, Ontario, M2R 1N5, Canada

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 7, 2021
• First Posted: January 11, 2022
• Study Start: February 24, 2022
• Primary Completion: December 1, 2022
• Study Completion: December 1, 2022
• Last Updated: June 25, 2026

Record last verified: 2026-06

Locations

CA (1)